VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
BAE Systems plc vs Gilead Sciences, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
BAE Systems plc
BA. · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into BAE Systems plc's moat claims, evidence, and risks.
View BA. analysisGilead Sciences, Inc.
GILD · NASDAQ Global Select Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Gilead Sciences, Inc.'s moat claims, evidence, and risks.
View GILD analysisComparison highlights
- Moat score gap: BAE Systems plc leads (75 / 100 vs 74 / 100 for Gilead Sciences, Inc.).
- Segment focus: BAE Systems plc has 5 segments (26.6% in Electronic Systems); Gilead Sciences, Inc. has 5 segments (68.5% in HIV).
- Moat breadth: BAE Systems plc has 8 moat types across 3 domains; Gilead Sciences, Inc. has 8 across 3.
Primary market context
BAE Systems plc
Electronic Systems
Defence electronics (electronic warfare, avionics, C4ISR, space payloads and mission systems)
Primarily US and UK; global programmes
Government defence and intelligence agencies; prime contractors
Subsystem OEM and prime contractor for electronics/mission systems
26.6%
Gilead Sciences, Inc.
HIV
HIV treatment and prevention medicines (antiretroviral therapy and PrEP)
Global (U.S. and Europe are major markets)
Patients/prescribers; reimbursed by public and private payers; distributed via wholesalers and specialty pharmacies
Drug developer and marketing authorization holder
68.5%
Side-by-side metrics
Moat coverage
Shared moat types
BAE Systems plc strengths
Gilead Sciences, Inc. strengths
Segment mix
BAE Systems plc segments
Full profile >Electronic Systems
Oligopoly
Platforms & Services
Oligopoly
Air
Oligopoly
Maritime
Oligopoly
Cyber & Intelligence
Competitive
Gilead Sciences, Inc. segments
Full profile >HIV
Oligopoly
Oncology (Cell Therapy + Trodelvy)
Oligopoly
Liver Disease
Oligopoly
Veklury (Remdesivir)
Competitive
Other Products
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.